Chenshen Huang
389 Xincun Road
Xincun, 200065, China
Xincun, 200065, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
KRASG12D inhibition reprograms the tumor-induced immunosuppressive environment and enhances NK cell-mediated antitumor immunity.
Journal: Science advances
Published: July 23, 2026
Tumor-intrinsic immune-genetic dynamics identify RNASE1 as an immune-evasion-associated biomarker and predictor of checkpoint blockade response in gastric adenocarcinoma.
Journal: Frontiers in immunology
Published: May 18, 2026
Reply to: Clarifying multimodal inputs and attribution in colorectal cancer survival prediction.
Journal: NPJ digital medicine
Published: February 02, 2026
A multi-dimensional omics framework identifies GPR35 as a driver of M2 macrophage activation and poor prognosis in colorectal cancer.
Journal: Frontiers in immunology
Published: January 08, 2026
Geometric multi-instance learning for weakly supervised gastric cancer segmentation.
Journal: NPJ digital medicine
Published: September 30, 2025
A machine learning-derived immune-related prognostic model identifies PLXNA3 as a functional risk gene in colorectal cancer.
Journal: Frontiers in immunology
Published: June 25, 2025
Comparison of [99mTc]Tc-FAPI SPECT/CT and [18F]FDG PET/CT as predictive biomarkers for immunotherapy response in gastrointestinal cancer.
Journal: Scientific reports
Published: December 31, 2024
Uncovering the predictive and immunomodulatory potential of transient receptor potential melastatin family-related CCNE1 in pan-cancer.
Journal: Molecular cancer
Published: June 16, 2024
Deciphering the role of LGALS2: insights into tertiary lymphoid structure-associated dendritic cell activation and immunotherapeutic potential in breast cancer patients.
Journal: Molecular cancer
Published: May 17, 2024
Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition.
Journal: Cancer letters
Published: November 02, 2023
FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion.
Journal: Journal of hematology & oncology
Published: September 05, 2023
Last Updated: 09/26/2026